Click for best price
HIV Therapeutics Market Size, Share 2022
The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss of ability to fight against the organism that causes disease.
This report contains market size and forecasts of HIV Therapeutics in Global, including the following market information:
Global HIV Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global HIV Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of HIV Therapeutics include Boehringer Ingelheim International GmbH, Merck & Co., ViiV Healthcare, AbbVie, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb, Gilead Sciences and Johnson & Johnson and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the HIV Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global HIV Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global HIV Therapeutics Market Segment Percentages, by Type, 2021 (%)
Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Entry and Fusion Inhibitors
Protease Inhibitors (PIs)
Integrase Inhibitors
Coreceptor Antagonists
Global HIV Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global HIV Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Labs
Global HIV Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global HIV Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies HIV Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies HIV Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer Ingelheim International GmbH
Merck & Co.
ViiV Healthcare
AbbVie
F. Hoffmann-La Roche Ltd.
Teva Pharmaceutical Industries Ltd.
Bristol-Myers Squibb
Gilead Sciences
Johnson & Johnson
Cipla Limited
| Report Attributes |
Report Details |
| Report Title |
HIV Therapeutics Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 HIV Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global HIV Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global HIV Therapeutics Overall Market Size
2.1 Global HIV Therapeutics Market Size: 2021 VS 2028
2.2 Global HIV Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top HIV Therapeutics Players in Global Market
3.2 Top Global HIV Therapeutics Companies Ranked by Revenue
3.3 Global HIV Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 HIV Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies HIV Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 HIV Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 HIV Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 HIV Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global HIV Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
4.1.3 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
4.1.4 Entry and Fusion Inhibitors
4.1.5 Protease Inhibitors (PIs)
4.1.6 Integrase Inhibitors
4.1.7 Coreceptor Antagonists
4.2 By Type - Global HIV Therapeutics Revenue & Forecasts
4.2.1 By Type - Global HIV Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global HIV Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global HIV Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global HIV Therapeutics Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Labs
5.2 By Application - Global HIV Therapeutics Revenue & Forecasts
5.2.1 By Application - Global HIV Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global HIV Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global HIV Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global HIV Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global HIV Therapeutics Revenue & Forecasts
6.2.1 By Region - Global HIV Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global HIV Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global HIV Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America HIV Therapeutics Revenue, 2017-2028
6.3.2 US HIV Therapeutics Market Size, 2017-2028
6.3.3 Canada HIV Therapeutics Market Size, 2017-2028
6.3.4 Mexico HIV Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe HIV Therapeutics Revenue, 2017-2028
6.4.2 Germany HIV Therapeutics Market Size, 2017-2028
6.4.3 France HIV Therapeutics Market Size, 2017-2028
6.4.4 U.K. HIV Therapeutics Market Size, 2017-2028
6.4.5 Italy HIV Therapeutics Market Size, 2017-2028
6.4.6 Russia HIV Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries HIV Therapeutics Market Size, 2017-2028
6.4.8 Benelux HIV Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia HIV Therapeutics Revenue, 2017-2028
6.5.2 China HIV Therapeutics Market Size, 2017-2028
6.5.3 Japan HIV Therapeutics Market Size, 2017-2028
6.5.4 South Korea HIV Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia HIV Therapeutics Market Size, 2017-2028
6.5.6 India HIV Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America HIV Therapeutics Revenue, 2017-2028
6.6.2 Brazil HIV Therapeutics Market Size, 2017-2028
6.6.3 Argentina HIV Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa HIV Therapeutics Revenue, 2017-2028
6.7.2 Turkey HIV Therapeutics Market Size, 2017-2028
6.7.3 Israel HIV Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia HIV Therapeutics Market Size, 2017-2028
6.7.5 UAE HIV Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Boehringer Ingelheim International GmbH
7.1.1 Boehringer Ingelheim International GmbH Corporate Summary
7.1.2 Boehringer Ingelheim International GmbH Business Overview
7.1.3 Boehringer Ingelheim International GmbH HIV Therapeutics Major Product Offerings
7.1.4 Boehringer Ingelheim International GmbH HIV Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Boehringer Ingelheim International GmbH Key News
7.2 Merck & Co.
7.2.1 Merck & Co. Corporate Summary
7.2.2 Merck & Co. Business Overview
7.2.3 Merck & Co. HIV Therapeutics Major Product Offerings
7.2.4 Merck & Co. HIV Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Merck & Co. Key News
7.3 ViiV Healthcare
7.3.1 ViiV Healthcare Corporate Summary
7.3.2 ViiV Healthcare Business Overview
7.3.3 ViiV Healthcare HIV Therapeutics Major Product Offerings
7.3.4 ViiV Healthcare HIV Therapeutics Revenue in Global Market (2017-2022)
7.3.5 ViiV Healthcare Key News
7.4 AbbVie
7.4.1 AbbVie Corporate Summary
7.4.2 AbbVie Business Overview
7.4.3 AbbVie HIV Therapeutics Major Product Offerings
7.4.4 AbbVie HIV Therapeutics Revenue in Global Market (2017-2022)
7.4.5 AbbVie Key News
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 F. Hoffmann-La Roche Ltd. Corporate Summary
7.5.2 F. Hoffmann-La Roche Ltd. Business Overview
7.5.3 F. Hoffmann-La Roche Ltd. HIV Therapeutics Major Product Offerings
7.5.4 F. Hoffmann-La Roche Ltd. HIV Therapeutics Revenue in Global Market (2017-2022)
7.5.5 F. Hoffmann-La Roche Ltd. Key News
7.6 Teva Pharmaceutical Industries Ltd.
7.6.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
7.6.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.6.3 Teva Pharmaceutical Industries Ltd. HIV Therapeutics Major Product Offerings
7.6.4 Teva Pharmaceutical Industries Ltd. HIV Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Teva Pharmaceutical Industries Ltd. Key News
7.7 Bristol-Myers Squibb
7.7.1 Bristol-Myers Squibb Corporate Summary
7.7.2 Bristol-Myers Squibb Business Overview
7.7.3 Bristol-Myers Squibb HIV Therapeutics Major Product Offerings
7.7.4 Bristol-Myers Squibb HIV Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Bristol-Myers Squibb Key News
7.8 Gilead Sciences
7.8.1 Gilead Sciences Corporate Summary
7.8.2 Gilead Sciences Business Overview
7.8.3 Gilead Sciences HIV Therapeutics Major Product Offerings
7.8.4 Gilead Sciences HIV Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Gilead Sciences Key News
7.9 Johnson & Johnson
7.9.1 Johnson & Johnson Corporate Summary
7.9.2 Johnson & Johnson Business Overview
7.9.3 Johnson & Johnson HIV Therapeutics Major Product Offerings
7.9.4 Johnson & Johnson HIV Therapeutics Revenue in Global Market (2017-2022)
7.9.5 Johnson & Johnson Key News
7.10 Cipla Limited
7.10.1 Cipla Limited Corporate Summary
7.10.2 Cipla Limited Business Overview
7.10.3 Cipla Limited HIV Therapeutics Major Product Offerings
7.10.4 Cipla Limited HIV Therapeutics Revenue in Global Market (2017-2022)
7.10.5 Cipla Limited Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. HIV Therapeutics Market Opportunities & Trends in Global Market
Table 2. HIV Therapeutics Market Drivers in Global Market
Table 3. HIV Therapeutics Market Restraints in Global Market
Table 4. Key Players of HIV Therapeutics in Global Market
Table 5. Top HIV Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global HIV Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global HIV Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies HIV Therapeutics Product Type
Table 9. List of Global Tier 1 HIV Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 HIV Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global HIV Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - HIV Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - HIV Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global HIV Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - HIV Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - HIV Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global HIV Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global HIV Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global HIV Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America HIV Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America HIV Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe HIV Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe HIV Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia HIV Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia HIV Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America HIV Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America HIV Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa HIV Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa HIV Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Boehringer Ingelheim International GmbH Corporate Summary
Table 31. Boehringer Ingelheim International GmbH HIV Therapeutics Product Offerings
Table 32. Boehringer Ingelheim International GmbH HIV Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Merck & Co. Corporate Summary
Table 34. Merck & Co. HIV Therapeutics Product Offerings
Table 35. Merck & Co. HIV Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. ViiV Healthcare Corporate Summary
Table 37. ViiV Healthcare HIV Therapeutics Product Offerings
Table 38. ViiV Healthcare HIV Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. AbbVie Corporate Summary
Table 40. AbbVie HIV Therapeutics Product Offerings
Table 41. AbbVie HIV Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. F. Hoffmann-La Roche Ltd. Corporate Summary
Table 43. F. Hoffmann-La Roche Ltd. HIV Therapeutics Product Offerings
Table 44. F. Hoffmann-La Roche Ltd. HIV Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Teva Pharmaceutical Industries Ltd. Corporate Summary
Table 46. Teva Pharmaceutical Industries Ltd. HIV Therapeutics Product Offerings
Table 47. Teva Pharmaceutical Industries Ltd. HIV Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Bristol-Myers Squibb Corporate Summary
Table 49. Bristol-Myers Squibb HIV Therapeutics Product Offerings
Table 50. Bristol-Myers Squibb HIV Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Gilead Sciences Corporate Summary
Table 52. Gilead Sciences HIV Therapeutics Product Offerings
Table 53. Gilead Sciences HIV Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Johnson & Johnson Corporate Summary
Table 55. Johnson & Johnson HIV Therapeutics Product Offerings
Table 56. Johnson & Johnson HIV Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Cipla Limited Corporate Summary
Table 58. Cipla Limited HIV Therapeutics Product Offerings
Table 59. Cipla Limited HIV Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. HIV Therapeutics Segment by Type in 2021
Figure 2. HIV Therapeutics Segment by Application in 2021
Figure 3. Global HIV Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global HIV Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global HIV Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by HIV Therapeutics Revenue in 2021
Figure 8. By Type - Global HIV Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global HIV Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global HIV Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America HIV Therapeutics Revenue Market Share, 2017-2028
Figure 12. US HIV Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada HIV Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico HIV Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe HIV Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany HIV Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France HIV Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. HIV Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy HIV Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia HIV Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries HIV Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux HIV Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia HIV Therapeutics Revenue Market Share, 2017-2028
Figure 24. China HIV Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan HIV Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea HIV Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia HIV Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India HIV Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America HIV Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil HIV Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina HIV Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa HIV Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey HIV Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel HIV Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia HIV Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE HIV Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Boehringer Ingelheim International GmbH HIV Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck & Co. HIV Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. ViiV Healthcare HIV Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. AbbVie HIV Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. F. Hoffmann-La Roche Ltd. HIV Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Teva Pharmaceutical Industries Ltd. HIV Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bristol-Myers Squibb HIV Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Gilead Sciences HIV Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Johnson & Johnson HIV Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Cipla Limited HIV Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
